SHPH SHPH
Company Profile ↓Company Overview
SHPH (SHPH) is a publicly traded company listed on with a market capitalization of $930.86K. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.10.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -86.86% |
| 6 Months: | -75.00% |
| 3 Months: | -41.70% |
| 1 Month: | +41.10% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMABelow
- RSI (14)61.88 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 90.3% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.95M | 3.91M | 2.27M | 2.79M | 2.22M |
| Operating Income | - | - | -242.12K | -638.40K | -353.63K | -821.47K | -1.54M | -1.47M | -1.60M | -1.38M | -1.48M | -3.05M | - | -2.95M | -3.91M | -2.27M | -2.79M | -2.22M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.04M | -3.68M | -2.33M | -2.31M | -1.51M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.93K | 21.74K | 18.90K | 18.25K | 12.12K |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.05M | -3.71M | -2.35M | -2.61M | -2.15M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -129.32K | -346.80K | -216.96K | -681.84K | -597.27K | -998.42K | -975.10K | -2.18M | -1.79M | -1.73M | -2.03M | -3.78M | - | -3.05M | -3.71M | -2.35M | -2.61M | -2.15M |
| Diluted EPS | - | - | - | - | -0.06 | -0.10 | -0.07 | -1.23 | -0.91 | -0.83 | -24.12 | -39.83 | - | -76.00 | -32.90 | -10.50 | - | -4.30 |
| R&D Expense | - | - | 186.96K | 295.92K | 83.87K | 669.04K | 921.80K | 839.66K | 1.05M | 586.10K | 645.72K | 1.40M | - | 1.57M | 1.03M | 943.48K | - | 267.24K |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 2.34M | 5.89M | 7.70M | 11.92M |
| Operating Income | - | -2.34M | -5.89M | -7.70M | -11.92M |
| EBITDA | - | -4.51M | -3.99M | -7.78M | -11.36M |
| Interest Expense | - | 480.70K | 2.60M | 1.36M | 70.83K |
| Pretax Income | - | -5.00M | -6.59M | -9.14M | -11.72M |
| Tax Provision | 0 | 0 | - | - | - |
| Net Income | - | -5.00M | -6.59M | -9.14M | -11.72M |
| Diluted EPS | - | -1,260.00 | -882.50 | -826.00 | -71.60 |
| R&D Expense | 1.02M | 1.15M | 3.52M | 3.62M | 4.05M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | - | - | 8.65M | 5.95M | 2.51M | 10.48M |
| Current Assets | - | - | 8.58M | 5.59M | 2.21M | 502.91K |
| Cash & Equivalents | - | - | 8.42M | 2.58M | 1.92M | 334.00K |
| Inventory | - | - | - | - | - | - |
| Receivables | - | 0 | - | - | - | - |
| Total Liabilities | - | - | 975.68K | 1.90M | 1.80M | 8.22M |
| Current Liabilities | - | - | 975.68K | 1.04M | 1.53M | 7.97M |
| Long Term Debt | - | - | - | 135.09K | - | - |
| Total Debt | - | - | 748.30K | 1.09M | 1.17M | 232.15K |
| Total Equity | -1.69M | - | 7.68M | 4.06M | 709.15K | 2.25M |
| Shares Outstanding | - | - | 6.80K | 8.03K | 16.31K | 202.36K |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -2.67M | -5.58M | -7.33M | -9.48M |
| Investing Cash Flow | - | 0 | -2.83M | 2.92M | -3.06M |
| Financing Cash Flow | - | 10.58M | 2.57M | 3.76M | 10.95M |
| Capital Expenditure | - | - | -19.05K | - | -3.06M |
| Free Cash Flow | - | -2.67M | -5.60M | -7.33M | -12.54M |
| Net Change in Cash | - | 7.91M | -5.84M | -656.27K | -1.59M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | - | - | - | - |
| ROE % | - | -65.1% | -162.6% | -1,289.5% | -519.9% |
| ROCE % | - | -30.5% | -120.0% | -791.4% | -474.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SHPH
SHPH, ILLR, IVF: Why These Stocks Posted Double-Digit Gains After-Hours Today
AI infrastructure plan, SpaceX exposure, and Nasdaq compliance update boosted investor sentiment.
Shuttle to Acquire United Dogecoin in Push to Build Public DOGE Mining Platform
Shuttle Pharmaceuticals Holdings (NASDAQ: $SHPH) said it has signed a definitive merger agreement to acquire United...
RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
Gaithersburg, Maryland--(Newsfile Corp. - March 27, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), today announced a major advancement to its molecule.ai platform, significantly expanding …
Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows
Gaithersburg, Maryland--(Newsfile Corp. - March 26, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), today announced a major advancement to its molecule.ai platform, significantly expanding …
E.F. Hutton & Co. Serves as Exclusive Placement Agent on Shuttle Pharmaceuticals’ $3.5 Million Public Offering
NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), a leading investment banking and financial advisory firm, today announced that it acted as the exclusive placement agent in connection with a $3.5 million publi…
Shuttle Pharmaceuticals Announces $3.5 Million Public Offering
Gaithersburg, Maryland--(Newsfile Corp. - March 6, 2026) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), the owner of Molecule.ai, an artificial intelligence ("AI") driven platform for molecular …
SHPH — Frequently Asked Questions
What is the current share price of SHPH?
As of 2026-08-05 17:25 PDT, SHPH trades at $4.60 on NASDAQ/NYSE. Its 52-week range is $2.78 to $47.60.
What is the market capitalisation of SHPH?
SHPH has a market capitalisation of $930.86K on NASDAQ/NYSE.
What is the P/E ratio of SHPH?
SHPH trades at a trailing price-to-earnings (P/E) ratio of -0.06. Its price-to-book (P/B) ratio is 0.41.
Is SHPH a good stock to buy?
This page provides a data-driven analysis of SHPH, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.